I came across a crazy piece of data today. The market cap of Novo Nordisk, the creator of the drug Ozempic, is now larger than the GDP of its own country, Denmark.
Although these measures are not like for like, it does illustrate Novo Nordisk’s outsized and impressive role in the Danish economy. It also goes to show how the rise of semaglutide has had a profound impact on the world in a short period of time.